Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-10FDA Approved: DURYSTA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Durysta (bimatoprost) from Allergan, Inc., to modify the product’s labeling and/or approved …
-
FDA approval · 2024-10-10FDA Approved: TIMOLOL HEMIHYDRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for Timolol hemihydrate, a generic ophthalmic solution, from Somerset Therapeutics, LLC.
-
FDA approval · 2024-10-09FDA Approved: XELPROS — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for XELPROS (latanoprost) submitted by Sun Pharmaceutical Industries.
-
FDA approval · 2024-09-18FDA Approved: RHOPRESSA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approves a supplemental application for RHOPRESSA (netarsudil) filed by Alcon Laboratories, Inc.
-
FDA approval · 2024-09-16FDA Approved: IYUZEH — Supplemental Application (Thea Pharma Inc.)
FDA approves a supplemental application for IYUZEH (latanoprost ophthalmic solution 0.005%). This approval expands the product's labeling re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-16FDA Approved: TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for TIMOLOL MALEATE (generic) by Somerset Therapeutics, LLC, for ophthalmic use to treat elevated intr…
-
FDA approval · 2024-09-10FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a new original application for a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate for lowering intra…
-
FDA approval · 2024-08-09FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Brimonidine Tartrate, a generic ophthalmic solution, enabling its sale for lowering intraocula…
-
FDA approval · 2024-08-07FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Travoprost Ophthalmic Solution 0.004% from Mylan, establishing a generic version of travoprost f…
-
FDA approval · 2024-08-07FDA Approved: TIMOLOL MALEATE — Original Application (Caplin Steriles Limited)
FDA approved Caplin Steriles Limited's original ANDA for Timolol Maleate, a generic eye drop product.
-
FDA approval · 2024-07-25FDA Approved: ISTALOL — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for ISTALOL (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
FDA approval · 2024-05-16FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic fixed-dose combination eye drops containing brimonidine tartrate and timolol maleate for reducing intraocula…
-
FDA approval · 2024-04-25FDA Approved: BRINZOLAMIDE — Supplemental Application (Oceanside Pharmaceuticals.)
The FDA approved a supplemental application for Brinzolamide submitted by Oceanside Pharmaceuticals. The approval concerns the generic drug …
-
FDA approval · 2024-03-29FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for travoprost ophthalmic solution 0.004% by Mylan Pharmaceuticals, expanding access to a generic pr…
-
FDA approval · 2024-03-04FDA Approved: BRIMONIDINE — Original Application (Sandoz Inc)
The FDA approved Sandoz's original ANDA for brimonidine tartrate ophthalmic solution, establishing a generic version of this glaucoma medica…
-
FDA approval · 2024-02-20FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for a dorzolamide hydrochloride-timolol maleate eye drop manufactured by Indoco Remedies Limited.
-
FDA approval · 2024-02-20FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC — Supplemental Application (Florida Pharmaceutical Products, LLC)
FDA approved a supplemental application for dorzolamide hydrochloride ophthalmic solution filed by Florida Pharmaceutical Products, LLC.
-
FDA approval · 2024-02-13FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for bimatoprost from Apotex Corp., authorizing a regulatory change under the ANDA framework.
-
FDA approval · 2023-12-27FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for latanoprost filed by Bausch & Lomb Incorporated.
-
FDA approval · 2023-11-28FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for bimatoprost filed by Alembic Pharmaceuticals Limited.
-
FDA approval · 2023-10-10FDA Approved: LATANOPROST — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for latanoprost by Aurobindo Pharma Limited, approving a generic ophthalmic latanoprost product.…
-
FDA approval · 2023-09-22FDA Approved: LATANOPROST — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for latanoprost from Rising Pharma Holdings, Inc., granting a new generic latanoprost product un…
-
FDA approval · 2023-09-11FDA Approved: ACETAZOLAMIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for acetazolamide (generic).
-
FDA approval · 2023-08-25FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for a fixed-dose combination eye drop containing brimonidine tartrate and timolol maleate, manufacture…
-
FDA approval · 2023-08-14FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for dorzolamide hydrochloride and timolol maleate ophthalmic solution from Bausch & Lomb Incorporate…